Salomon & Ludwin’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$732 Hold
2
– – ﹤0.01% 1657
2026
Q2
$581 Hold
2
– – ﹤0.01% 2050
2026
Q1
$622 Hold
2
– – ﹤0.01% 2032
2025
Q4
$641 Hold
2
– – ﹤0.01% 2080
2025
Q3
$688 Hold
2
– – ﹤0.01% 2073
2025
Q2
$489 Hold
2
– – ﹤0.01% 839
2025
Q1
$544 Hold
2
– – ﹤0.01% 672
2024
Q4
$369 Hold
2
– – ﹤0.01% 690
2024
Q3
$449 Hold
2
– – ﹤0.01% 693
2024
Q2
$285 Hold
2
– – ﹤0.01% 708
2024
Q1
$313 Buy
+2
New +$322 ﹤0.01% 820

Other funds holding ONC

Salomon & Ludwin's ONC Position: Q3 2026 in Review

Salomon & Ludwin held its BeOne Medicines (ONC) position steady in Q3 2026 at 2 shares worth $732. The position accounts for ﹤0.01% of the portfolio, ranked #1657.

Salomon & Ludwin first reported a position in ONC in Q1 2024 and has held it in 11 quarters since. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Salomon & Ludwin held 2 shares of BeOne Medicines worth $732 as of Q3 2026.
  • Salomon & Ludwin left its BeOne Medicines share count unchanged in Q3 2026.
  • BeOne Medicines made up ﹤0.01% of Salomon & Ludwin's portfolio in Q3 2026, its #1657 holding.
  • Salomon & Ludwin first reported a position in BeOne Medicines in Q1 2024 and has held it in 11 quarters since.
  • 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Salomon & Ludwin's 13F filing for Q3 2026, filed 29 Oct 2026.